Clinical events and echocardiographic lesion progression rate in subjects with mild or moderate aortic regurgitation

被引：8

作者：

Badiani S. ^{[1
,2
]}

Van Zalen J. ^{[1
,2
]}

Saheecha S. ^{[1
]}

Hart L. ^{[1
]}

Topham A. ^{[1
]}

Patel N. ^{[1
]}

Sturridge L. ^{[3
]}

Marshall A. ^{[1
]}

Sulke N. ^{[1
]}

Furniss S. ^{[1
]}

Lloyd G. ^{[1
,2
]}

机构：

[1] East Sussex Healthcare NHS Trust, Eastbourne District General Hospital, East Sussex

[2] Barts Heart Centre, St Bartholomew's Hospital, London

[3] Frimley Park Hospital, Surrey

来源：

Echo Research & Practice | 2017年 / 4卷 / 3期

关键词：

AR; Echocardiography; Valvular heart disease;

D O I：

10.1530/ERP-17-0002

中图分类号：

学科分类号：

摘要：

Background: The rate of progression of aortic regurgitation (AR) is not well described. Current guidelines state that asymptomatic patients with mild AR should be followed up every 3-5 years and 1-2 yearly for moderate AR. This study describes the lesion and clinical based progression of mild and moderate AR in a population of patients undergoing systematic follow-up. Methods and results: 341 patients with either mild or moderate AR were included. The rates of clinical events (death, aortic valve replacement and cardiac hospitalization) and progression of AR are reported. 341 patients were included; mean age was 71.1 years (IQR 66-80 years) and the median follow-up period was 4.6 (IQR 2-6.7) years. 292 patients did not have any events during follow-up. 3 patients required aortic valve replacement (2 of these due to severe aortic stenosis and 1 due to severe mitral regurgitation and co-existent moderate AR). 44 patients required cardiac hospitalization. 9 patients died during follow-up and 35 patients (10%) showed a progression of AR during follow-up with an average time of 4.0 ± 2.6 years. 8 patients (2.3% of the total) progressed to severe AR. Patients with mixed valvular pathology showed a greater increase in AR progression (27 (15%) vs 8 (5%); P = 0.004). Conclusions: Over medium term systematic follow-up progression and clinical events in patients with AR is rare, regardless of etiology. Patients who suffered from AR as an isolated valve pathology were less likely to show AR progression over time. © 2017 The authors.

引用

页码：37 / 44

页数：7

共 32 条

[1]

Nkomo V.T., Gardin J.M., Skelton T.N., Gottdiener J.S., Scott C.G., Enriquez-Sarano M., Burden of valvular heart diseases: A population-based study, Lancet, 368, pp. 1005-1011, (2006)

[2]

Singh J.P., Evans J.C., Levy D., Larson M.G., Freed L.A., Fuller D.L., Lehman B., Benjamin E.J., Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study), American Journal of Cardiology, 83, pp. 897-902, (1999)

[3]

Lebowitz N.E., Bella J.N., Roman M.J., Liu J.E., Fishman D.P., Paranica S.M., Lee E.T., Fabsitz R.R., Welty T.K., Howard B.V., Et al., Prevalence and correlates of aortic regurgitation in American Indians: The Strong Heart Study, Journal of the American College of Cardiology, 36, pp. 461-467, (2000)

[4]

D'Arcy J.L., Coffey S., Loudon M.A., Kennedy A., Pearson-Stuttard J., Birks J., Frangai E., Farmer A.J., Mant D., Wilson J., Et al., Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: The OxVALVE Population Cohort Study, European Heart Journal, 37, pp. 3515-3522, (2016)

[5]

Dujardin K.S., Enriquez-Sarano M., Schaff H.V., Bailey K.R., Seward J.B., Tajik A.J., Mortality and morbidity of aortic regurgitation in clinical practice, a long-term follow-up study, Circulation, 99, pp. 1851-1857, (1999)

[6]

Fedak P.W.M., Verma S., David T.E., Leask R.L., Weisel R.D., Butany J., Clinical and pathophysiological implications of a bicuspid aortic valve, Circulation, 106, pp. 900-904, (2002)

[7]

Roman M.J., Devereux R.B., Niles N.W., Hochreiter C., Kligfield P., Sato N., Spitzer M.C., Borer J.S., Aortic root dilatation as a cause of isolated, severe aortic regurgitation. Prevalence, clinical and echocardiographic patterns, and relation to left ventricular hypertrophy and function, Annals of Internal Medicine, 106, pp. 800-807, (1987)

[8]

Bonow R.O., Lakatos E., Maron B.J., Epstein S.E., Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function, Circulation, 84, pp. 1625-1635, (1991)

[9]

Scognamiglio R., Negut C., Palasi M., Fasoli G., Dalla V.S., Progression of myocadial dysfunction in asymptomatic patients with severe aortic insufficiency, Clinical Cardiology, 9, pp. 151-156, (1986)

[10]

Siemienczuk D., Greenburg B., Morris G., Massie B., Wilson R.A., Topic N., Bristow J.D., Cheitlin M., Chronic aortic insufficiency: Factors associated with progression to aortic valve replacement, Annals of Internal Medicine, 110, pp. 587-592, (1989)

← 1 2 3 4 →